Northlane Capital invests in Firma
Summary
NCP invested alongside Firma’s existing management team and healthcare industry veteran Michael Woods, who joined Firma as CEO at close.With locations in Chicago, IL and Hunt Valley, MD, Firma provides support services to biopharmaceutical and medical device companies as part of the drug and product development process, most notably in the areas of remote patient visit and data management/biostatistical services.“Our investment in Firma demonstrates an ideal scenario for NCP – identifying a growing niche within the pharmaceutical services sector, investing in a company with a strong value proposition and leading market position, and partnering with an experienced operating executive from our network,” said Justin DuFour, Partner at NCP.I have been impressed with the company’s performance, reputation for quality, and track record of innovation with respect to its patient-centric service offerings.Scott Kauffman, Principal at NCP, added, “This transaction will provide Firma with additional resources to further enhance its global service offering and technology capabilities to existing customers and clinical trial participants, and to further expand the company’s customer base.”